Transthyretin Amyloid Cardiomyopathy (ATTR-CM) trials recruiting in Connecticut

Fewer than 3 recruiting trials found.

All Transthyretin Amyloid Cardiomyopathy (ATTR-CM) trials nationally

Cities in Connecticut

Recruiting trials in Connecticut

• CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
  NCT07207811 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Connecticut: New Haven